![](/img/cover-not-exists.png)
PDB37 MEALTIME INSULIN ASPART REDUCES THE LONG-TERM COST OF COMPLICATIONS COMPARED TO HUMAN INSULIN AS PART OF BASAL-BOLUS THERAPY IN POLISH TYPE 2 DIABETES PATIENTS
G Goodall, S Nielsen, C Townsend, R Kotchie, K Erny-Albrecht, WJ ValentineVolume:
10
Year:
2007
Language:
english
DOI:
10.1016/s1098-3015(10)64985-6
File:
PDF, 72 KB
english, 2007